Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Emerging Markets Earnings Roundup: Abbott, AbbVie, J&J And Novartis (Part 3)

This article was originally published in PharmAsia News

Executive Summary

In Part 3 of our feature, we take a closer look at the first quarterly calls for Abbott and AbbVie after the company split in two, plus the latest on emerging markets from J&J and Novartis.

Advertisement

Related Content

AbbVie Sets Out To Win Over Investors In Its First Financial Call
J&J Considers Sale, Spin-Off For Ortho-Clinical Diagnostics
Top Changes At Bayer And Novartis As Vasella Goes, Reinhardt Returns
J&J Will Boost OTC Marketing Once Reliable Production Returns
Bayer’s Reinhardt Returning To Novartis To Replace Departing Vasella
New Competition, Procedure Declines Challenge Abbott Vascular In Second Quarter
Follow The CEO? Abbott Chief Chooses Diversified Products, Emerging Markets Over Rx Drugs As Company Splits In Two
Could "Calculated Risks" In China Help Solve Global R&D Challenges? Bayer Thinks So
J&J Opens Device R&D Center In China For Growing Rural Market
J&J, Medtronic Adapt To Changing Chinese Medical Device Market - Ernst &Young Report

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC083617

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel